Puma Biotechnology, Inc. (NASDAQ:PBYI) Q2 2024 Earnings Call Transcript August 1, 2024
Puma Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.1.
Operator: Good afternoon. My name is Diego and I will be your conference call operator today. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference call over to Mariann Ohanesian, Senior Director of IR for Puma Biotechnology. You may begin...
